Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» After EpiPen controversy, watchdog to review Medicaid rebates
After EpiPen controversy, watchdog to review Medicaid rebates
After EpiPen controversy, watchdog to review Medicaid rebates
Submitted by
admin
on December 10, 2016 - 10:28am
Source:
Stat/Pharmalot
News Tags:
Medicaid
Medicaid Drug Rebate Program
Mylan Labs
EpiPens
Headline:
After EpiPen controversy, watchdog to review Medicaid rebates
Do Not Allow Advertisers to Use My Personal information
